Search Results for keywords:"FDA notice"

The Food and Drug Administration (FDA) issued an order banning Jonathan Corbett Cosie from importing any drugs into the United States for 10 years. This decision follows his conviction for two federal felonies related to selling misbranded, unapproved drugs, including some that were falsely labeled and sold without a prescription. Mr. Cosie was notified of his debarment and given the opportunity to request a hearing, but he did not respond, waiving his right to contest the decision. The ban is effective as of March 13, 2025.

The Food and Drug Administration (FDA) is asking consumer organizations interested in selecting representatives for its advisory committees to notify the FDA in writing. They are also requesting nominations for consumer representatives, either voting or non-voting, for committees with current or upcoming vacancies. The FDA encourages diverse nominations, highlighting a desire for representation from various demographics, including racial and ethnic groups, as well as individuals with disabilities. The selection process involves organizations recommending nominees, and the FDA will compile a list of qualified candidates based on the recommendations received.

The Food and Drug Administration (FDA) has announced it will transfer regulatory responsibility for medical maggots and medicinal leeches from the Center for Devices and Radiological Health (CDRH) to the Center for Biologics Evaluation and Research (CBER), effective December 30, 2024. This decision was made because these products are living organisms, and CBER is more suited to regulate such products. The transfer only affects which FDA Center will oversee these products and does not change any existing requirements. After the transfer date, all submissions related to these products should be directed to CBER.